Colorcon header

Applied DNA and Colorcon, Inc. have signed a License and Cooperation Agreement, as well as a related Supply Agreement, for the use of SigNature® DNA molecular tags in Colorcon’s product offerings, and access to Applied DNA’s associated authentication technologies.

Under the terms of the Agreements, Applied DNA grants Colorcon exclusive worldwide right to use the Company’s molecular tags and associated authentication technologies in film coatings for solid oral dosage form (“SOD”) applications, for which Colorcon is the largest global supplier, and non-exclusive rights to use the Company’s technologies in inks and colorants for SOD applications.

Daniel To presented Novel Authentication Technology Using Molecular Tags as a PCID in Solid Oral Dosage Forms, a collaboration with Applied DNA Sciences, at AAPS 2019.

See the poster here.

“Molecular tags will provide traceability for audits and law enforcement and, perhaps most importantly, forensic confirmation of the authenticity of the drug product to the patient and all those in the supply chain, including the pharmacist, the drug distributors and manufacturers. We are gratified to be working with a world leader whose sales channel greatly amplifies our combined access to the market.”

Dr. James Hayward, President and CEO of Applied DNA

“Colorcon has an established reputation for innovation and service. Applied DNA’s SigNature molecular tags and authentication technologies provide value-addition at a time when regulators are demanding that the industry implement serialization in order to track packaging. The collaboration goes a significant step further by enabling traceability at the level of single unit, solid oral doses, and it is complementary to the provisions of the Drug Supply Chain Security Act.”

“Our teams are already actively engaged in discussions with potential customers.”

Kelly Boyer, General Manager Film Coatings Business Unit for Colorcon, Inc.

About Colorcon

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Colorcon’s best-in-class products and technologies are complemented by Colorcon’s extensive application data and value-added services to support all phases of solid oral dose design and development.  Colorcon’s focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice.  That reputation is based on the superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations.

Applied DNA launches subsidiary for COVID-19 test kits
SelectScience | Colorcon launches on-dose authentication technology platform for drug manufacturing
Securing Industry | Colorcon launches DNA-based on-dose authentication system
In-Pharma Technologist | An easy pill to swallow: Colorcon tech targets the old, young, and pill-fatigued
Chemicals Knowledge | Applied DNA signs agreement with Colorcon for molecular tagging
Securing Industry | Colorcon follows through on tablet-marking deal with APDN